FORT LAUDERDALE, Fla., May 11 /PRNewswire/ -- Star Pharmaceuticals today announced the launch of prescription-only Prosed EC, a line extension to their established brand of 40 years, Prosed/DS. Prosed EC is a unique formulation that provides fast relief of lower urinary tract symptoms such as pain, burning and spasm associated with urinary tract infections, interstitial cystitis and pre- and post-diagnostic procedures. Prosed EC is the same classic combination as Prosed/DS containing an analgesic, antispasmodics, and antiseptics with the addition of enteric coating which minimizes gastric upset. Star will be promoting Prosed EC to targeted physicians and pharmacists through a national sales force, telemarketing and direct mail.
Jerry Finley, CEO and Chairman of Star Pharmaceuticals, stated, "The development of Prosed EC is exemplary of our commitment to improve patients' lives. Prosed EC's enteric coating provides additional safety to the patient by minimizing gastric upset."
About Star Pharmaceuticals
Star Pharmaceuticals Inc. a Florida-based Corporation, was incorporated in 1961. Star is a specialty pharmaceutical company that develops, manufactures, markets and distributes prescription and over-the-counter (OTC) products in the genitourological, endocrinology, gynecology and ear care markets.
The companies hold 17 trademark listings and three product registrations. For more information, please visit http://www.starpharm.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Star's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and our ability to operate successfully in new lines of business.
For more information contact: Jerry Finley, Chairman and CEO Star Pharmaceuticals Inc. 1881 W. State Road 84 Suite 101 Fort Lauderdale, FL 33315-9975 Phone: 954-971-9704
Star Pharmaceuticals Inc.CONTACT: Jerry Finley, Chairman and CEO, Star Pharmaceuticals Inc.,+1-954-971-9704
Web site: http://www.starpharm.com/